Abbott Laboratories (FRA:ABL)
107.26
+0.58 (0.54%)
At close: Dec 5, 2025
Abbott Laboratories Revenue
Abbott Laboratories had revenue of $11.37B USD in the quarter ending September 30, 2025, with 6.90% growth. This brings the company's revenue in the last twelve months to $43.84B, up 6.37% year-over-year. In the year 2024, Abbott Laboratories had annual revenue of $41.95B with 4.59% growth.
Revenue (ttm)
$43.84B
Revenue Growth
+6.37%
P/S Ratio
5.00
Revenue / Employee
$384.59K
Employees
114,000
Market Cap
186.96B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 41.95B | 1.84B | 4.59% |
| Dec 31, 2023 | 40.11B | -3.54B | -8.12% |
| Dec 31, 2022 | 43.65B | 578.00M | 1.34% |
| Dec 31, 2021 | 43.08B | 8.47B | 24.47% |
| Dec 31, 2020 | 34.61B | 2.70B | 8.48% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Abbott Laboratories News
- 2 days ago - Muscles, the New Flex: Abbott Launches Two New Ensure® Max Protein Shakes to Tap into Growing Muscle Health Movement - PRNewsWire
- 6 days ago - This Top Dividend King Just Became an Even Better Buy - The Motley Fool
- 7 days ago - Best Dividend Aristocrats For December 2025 - Seeking Alpha
- 10 days ago - ABT Factor-Based Stock Analysis - Peter Lynch - Nasdaq
- 10 days ago - Eric Shroff Executes Sell Order: Offloads $203K In Abbott Laboratories Stock - Benzinga
- 11 days ago - Insider Sell: Eric Shroff Sells Shares of Abbott Laboratories (ABT) - GuruFocus
- 11 days ago - Abbott Launches Medical Device Correction For FreeStyle Libre 3 Glucose Sensors In U.S. - Nasdaq
- 12 days ago - Abbott issues US device correction for some glucose monitors over faulty readings risk - Reuters